Mind Cure Health Inc
CNSX:MCUR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its Industry Average (15.4), the stock would be worth CA$-1.03 (1 470% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1.1 | CA$0.08 |
0%
|
| Industry Average | 15.4 | CA$-1.03 |
-1 470%
|
| Country Average | 18.6 | CA$-1.24 |
-1 755%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CA |
M
|
Mind Cure Health Inc
CNSX:MCUR
|
7m CAD | -1.1 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
285.7B USD | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
99.6B ZAR | 10.3 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
67.4B USD | 38 074.9 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
57.3B USD | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
37.3B CHF | 0 | |
| US |
|
Coupang Inc
F:788
|
31.3B EUR | 173.5 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
34.5B USD | -3 263 | |
| US |
Q
|
Qnity Electronics Inc
NYSE:Q
|
29.6B USD | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 14.2 |
| Median | 18.6 |
| 70th Percentile | 29.3 |
| Max | 19 628.5 |
Other Multiples
Mind Cure Health Inc
Glance View
Mind Cure Health, Inc. operates as a life sciences company to identify and develop products that enhance mental health and wellness. The company is headquartered in Vancouver, British Columbia and currently employs 14 full-time employees. The company went IPO on 2020-09-21. The firm is engaged in developing digital therapeutics technology and researching psychedelic compounds to support science-backed and evidence-based mental health therapy globally. Its digital therapeutics tool, iSTRYM, is a software application that optimizes the healing journey for both patients and clinicians before, during, and after therapy sessions. Its bioinformatics platform, PsyCollage, helps drive research by identifying priority research programs. The company Desire Project is a clinical research program focused on the treatment of female hypoactive sexual desire disorder (HSDD) with 3,4-Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. The company is engaged in manufacturing synthetic ibogaine, which provides researchers and clinicians with the resources they need to promote healing related to addiction, migraines, cluster headaches, neuropathic pain, treatment-resistant mood disorders, and more.
